Mark Bachleda is Chief Commercial Officer at Galera Therapeutics, Inc. (GRTX). They have made 1 open-market trade across 1 company since 2023, most recently 2023-03-16.
CIK 0001887762
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GRTX | 11,000 | $2K |
Shares reported on the most recent Form 4, priced at the 2023-03-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GRTX | BUY | 2023-03-16 | 2023-03-20 | $2.25 | $25K | +10.9% | +24.5% | +39.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.